Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NRF2 mediates γ-globin gene regulation through epigenetic modifications in a β-YAC transgenic mouse model. | Exp Biol Med (Maywood) | 2020 | 32715783 | PubTator, text mining | PubMed |
| Self-Reporting Transposons Enable Simultaneous Readout of Gene Expression and Transcription Factor Binding in Single Cells. | Cell | 2020 | 32710817 | PubTator, text mining | PubMed |
| Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease. | J Clin Med | 2020 | 32708954 | PubTator, text mining | PubMed |
| Recent advances in understanding and management of bronchopulmonary dysplasia. | F1000Res | 2020 | 32704351 | PubTator, text mining | PubMed |
| LINE-1 ORF1p does not determine substrate preference for human/orangutan SVA and gibbon LAVA. | Mob DNA | 2020 | 32676128 | PubTator, text mining | PubMed |
| Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets. | NPJ Precis Oncol | 2020 | 32656360 | PubTator, text mining | PubMed |
| Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction. | Exp Cell Res | 2020 | 32653411 | PubTator, text mining | PubMed |
| Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo Studies. | J Pharmacol Exp Ther | 2020 | 32631869 | PubTator, text mining | PubMed |
| Human Norovirus Proteins: Implications in the Replicative Cycle, Pathogenesis, and the Host Immune Response. | Front Immunol | 2020 | 32612600 | PubTator, text mining | PubMed |
| Analysis of endothelial-to-haematopoietic transition at the single cell level identifies cell cycle regulation as a driver of differentiation. | Genome Biol | 2020 | 32611441 | PubTator, text mining | PubMed |
| Single-cell analysis of clonal maintenance of transcriptional and epigenetic states in cancer cells. | Nat Genet | 2020 | 32601473 | PubTator, text mining | PubMed |
| Non-deletional alpha thalassaemia: a review. | Orphanet J Rare Dis | 2020 | 32600445 | PubTator, text mining | PubMed |
| Epigenetic Reexpression of Hemoglobin F Using Reversible LSD1 Inhibitors: Potential Therapies for Sickle Cell Disease. | ACS Omega | 2020 | 32596612 | PubTator, text mining | PubMed |
| Thalassemia Major and Intermedia Patients in East Java do not Show Fetal Hemoglobin Level Difference in Relation to XMNI Polymorphism. | Med Arch | 2020 | 32577047 | PubTator, text mining | PubMed |
| Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin. | Sci Rep | 2020 | 32576837 | PubTator, text mining | PubMed |
| A hypothesis about the role of fetal hemoglobin in COVID-19. | Med Hypotheses | 2020 | 32570166 | PubTator, text mining | PubMed |
| UNC0638 induces high levels of fetal hemoglobin expression in β-thalassemia/HbE erythroid progenitor cells. | Ann Hematol | 2020 | 32567028 | PubTator, text mining | PubMed |
| Identification of immune and non-immune cells in regenerating axolotl limbs by single-cell sequencing. | Exp Cell Res | 2020 | 32562784 | PubTator, text mining | PubMed |
| Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation. | Drugs | 2020 | 32557398 | PubTator, text mining | PubMed |
| Association between acrylamide exposure and sex hormones in males: NHANES, 2003-2004. | PLoS One | 2020 | 32555690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=61